Threshold Pharmaceuticals, Inc. (Nasdaq: THLD) said the FDA has granted orphan drug designation to Threshold's product candidate ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE